Perrigo Company PLC

Healthcare · Drug Manufacturers - Specialty & Generic

14.70$ +6.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Perrigo Company PLC (PRGO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,023 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement PRGO
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	1,355	1,062	1,194	1,238	1,231	1,283	1,217	1,186	1,133	1,195	1,175	1,149	1,191	1,323	1,083	949	1,003	1,290	1,010	981	1,043	1,105	1,075	1,122	1,100	1,155	1,182	1,193	1,124	1,157	1,082	1,066	1,088	1,138	1,044	1,056	1,043	1,110	969	1,023	4,145
Cost of Revenue	849	606	730	733	734	770	724	715	708	752	726	718	778	842	690	602	633	820	642	632	706	743	737	750	737	773	768	765	713	730	724	671	683	752	652	693	666	747	644	709	2,766
Gross Profit	506	455	464	505	498	513	493	471	425	443	449	431	413	481	394	347	370	469	368	349	336	362	338	372	363	383	414	428	411	427	358	395	404	386	392	363	377	362	326	314	1,379
Research & Development	50	42	40	43	38	47	38	92	44	45	40	44	44	59	28	30	30	46	31	33	28	30	29	32	30	33	31	32	30	30	29	29	26	28	27	22	25	22	25	24	95
Selling, General & Administrative	109	135	105	98	123	134	108	97	106	126	125	127	132	119	120	114	111	138	127	110	131	114	122	158	106	126	135	133	126	129	130	126	117	95	112	113	94	319	267	100	781
Total Operating Expenses	335	357	285	316	324	348	335	371	307	337	333	336	342	488	307	285	291	521	317	475	-102	316	316	379	330	352	365	371	349	443	413	421	324	272	345	318	305	278	292	291	1,164
Operating Income	-1,515	98	129	149	162	159	156	95	-122	108	102	55	54	-6.9	86	63	79	-52	51	-126	438	47	22	-6.9	33	31	49	57	62	-16	-55	-27	80	114	47	45	73	85	34	24	215
Interest Expense	55	53	53	45	35	35	31	32	32	33	29	31	31	36	29	32	33	27	32	32	31	31	36	38	41	41	44	44	44	43	43	44	58	43	39	40	54	30	41	38	163
Pre-Tax Income	-1,572	-3,069	96	-76	129	132	111	55	-79	204	81	27	97	-34	57	16	48	-208	17	-157	389	9.9	-13	-108	-3.5	-14	4.3	23	19	-54	-99	-74	22	70	8.3	3.2	22	-1,332	-409	105	-1,612
Income Tax Expense	-316	-452	24	-6.7	84	59	30	19	-12	122	17	18	5.1	-15	-0.2	3.1	22	-33	14	-45	443	-22	-12	-43	49	-1.6	5.4	14	3.8	-27	-103	32	39	112	8.2	3.7	9.7	83	-19	17	91
Net Income	-1,255	-2,617	72	-70	45	73	81	36	-68	81	64	9.0	92	-19	106	61	-155	-175	38	-58	-59	9.6	-2.4	-65	-49	-24	-3.0	8.4	14	-32	2.0	-108	-21	-45	-6.4	-8.4	7.5	-1,418	-399	75	-1,735
EBITDA	267	-1.3	289	298	283	284	267	208	224	208	212	153	230	113	179	142	179	-81	139	-51	493	114	92	14	126	124	137	160	154	74	26	52	162	193	127	129	162	-1,246	-284	144	-1,225

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings